Table 3.
Uni- and multivariate Cox regression models for overall survival (OS) performed in the DDRon group (left columns) and in the DDRoff group (right columns).
| DDRon |
DDRoff |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Univariate Cox | Multivariate Cox | Univariate Cox | Multivariate Cox | ||||||
| regression model |
regression model |
regression model |
regression model |
||||||
| HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | ||
| PD-L1-TCs | Positive vs Negative | 1.61 (0.73–3.55) | 0.237 | 2.56 (1.06–6.16) | 0.036 | 0.44 (0.19–1.00) | 0.051 | 0.41 (0.17–0.96) | 0.039 |
| Stage | Metastatic vs locally advanced | 1.12 (0.50–2.47) | 0.787 | — | — | 1.58 (0.78—3.17) | 0.201 | — | — |
| N° of metastatic sites | 2—3 vs 1 | 1.98 (0.80—4.95) | 0.141 | — | — | 1.85(0.91—3.73) | 0.088 | 2.52 (1.18—5.39) | 0.017 |
| Taxanes | Yes vs No | 0.62 (0.26—1.46) | 0.274 | — | — | 0.72 (0.36—1.46) | 0.368 | — | — |
| Second-line chemotherapy | Yes vs No | 0.32 (0.13—0.78) | 0.012 | 0.23 (0.09—0.60) | 0.003 | 0.50 (0.24—1.03) | 0.062 | 0.44 (0.21—0.96) | 0.039 |
Backward stepwise exclusion.